Ocular Therapeutix, Inc. remote jobs and company guide

Ocular Therapeutix, Inc. is a biopharmaceutical company dedicated to redefining the retina experience for patients and physicians alike. Our customers face the significant burden of frequent, invasive eye treatments, which is why we are committed to developing innovative therapies that reduce this burden and improve long-term vision outcomes. We focus on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using our proprietary ELUTYX™ bioresorbable hydrogel-based formulation technology.

Our pipeline is led by AXPAXLI™ (axitinib intravitreal hydrogel), a potential best-in-class treatment for wet age-related macular degeneration (wet AMD) and diabetic retinopathy, designed to deliver sustained therapeutic levels of medication. Beyond our pipeline, we have successfully brought products to market, including DEXTENZA®, an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery, and ReSure® Sealant. By leveraging our unique hydrogel platform, we aim to transform the standard of care in ophthalmology, offering solutions that are not only effective but also designed with the patient's quality of life in mind.